The webinar provides a detailed overview of the considerations and guidelines for conducting Fcγ receptor binding studies, particularly for IgG1, IgG2, and IgG4 monoclonal antibodies. These studies are critical for understanding the therapeutic efficacy and immune system engagement of these antibodies. The document emphasizes the importance of accurate assay design and development, highlighting the use of the Octet® BLI Platform for real-time, label-free analysis of biomolecular binding interactions.

You will learn from this webinar:

• The interactions between IgG monoclonal antibodies and Fcγ receptors are crucial for the therapeutic action of these antibodies, necessitating detailed study and understanding.
• Assay design and development for IgG-Fcγ receptor binding studies must be carefully executed, considering various parameters to ensure precise measurement of binding kinetics and affinities.
• The Octet® BLI system is recommended for its ability to provide real-time, label-free analysis of IgG-Fcγ receptor binding, offering essential data for the development and optimization of monoclonal antibody therapies.

Who should attend

• Lab Director, Lab Manager, Research Assistant, Graduate Student, Postdoctoral Fellow, Research Scientist
• Bioprocess, Assay Development, and Protein Analysis Scientist
• Private Research, Contract Research, Biopharmaceutical, Biotech
• Academia Researchers in the field of Ab Development and Engineering